Loading asset research
NewcelX Ltd. Ordinary Shares
NCELNasdaq · USD · StocksQuote as of · Exchange session not verified$2.89
+1.05%
Today
NCEL
Loading 1D prices…
Market cap
$17.3M
Volume
4.2K
52w high
$24.6052w low
$1.83Company profile
NewcelX Ltd. Ordinary Shares
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
ZURICH, United States
Employees
9
Fiscal year end
1231
CIK
1783036
Session & valuation
Open$2.89
Previous close$2.86
Day high$2.90
Day low$2.76
30-day avg. volume9K
Outstanding shares4.8M
Diluted EPS$2.16
Latest annual period
P/E (trailing)5.36
P/E (forward)-5.00
Price / book2.68
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LPCNLipocine Inc. Common Stock | $17.4M | $2M | -487.18% | -$1.69 | -1.42% | Hold |
| BFRIBiofrontera Inc. Common Stock | $17.4M | $41.7M | -25.26% | -$1.04 | +4.35% | Buy |
| PTNPalatin Technologies Inc. Common Stock | $17.5M | $12.9M | -31.20% | -$1.63 | -4.28% | Unrated |
| ALLRAllarity Therapeutics Inc. Common Stock | $16.9M | $320K | -3509.69% | -$0.78 | +4.81% | Hold |
| CLRBCellectar Biosciences Inc. Common Stock | $17.9M | $0.00 | — | -$8.35 | -0.48% | Buy |